Mark A. Gill

1.3k total citations
60 papers, 987 citations indexed

About

Mark A. Gill is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark A. Gill has authored 60 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pharmacology, 11 papers in Pediatrics, Perinatology and Child Health and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark A. Gill's work include Antibiotics Pharmacokinetics and Efficacy (30 papers), Pharmaceutical studies and practices (9 papers) and Antibiotic Resistance in Bacteria (9 papers). Mark A. Gill is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (30 papers), Pharmaceutical studies and practices (9 papers) and Antibiotic Resistance in Bacteria (9 papers). Mark A. Gill collaborates with scholars based in United States, Japan and Norway. Mark A. Gill's co-authors include Stan G. Louie, Mark P. Okamoto, Alfred Chin, Paul M. Beringer, Bradley R. Williams, Jack W. Kern, Albert E. Yellin, Peter N.R. Heseltine, Kazuhiro Inagaki and Thomas V. Berne and has published in prestigious journals such as Annals of Surgery, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mark A. Gill

59 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Gill United States 17 422 199 157 114 105 60 987
J J Schentag United States 16 541 1.3× 223 1.1× 205 1.3× 126 1.1× 87 0.8× 32 1.0k
Allan H. Price United Kingdom 7 360 0.9× 160 0.8× 175 1.1× 76 0.7× 102 1.0× 9 1.0k
Karen I. Plaisance United States 17 434 1.0× 239 1.2× 137 0.9× 220 1.9× 58 0.6× 30 1.2k
Klaus Borner Germany 16 392 0.9× 222 1.1× 121 0.8× 123 1.1× 50 0.5× 33 1.1k
Lee B. Barradell 18 323 0.8× 257 1.3× 155 1.0× 181 1.6× 119 1.1× 24 1.3k
Jaya Natarajan United States 19 567 1.3× 345 1.7× 242 1.5× 108 0.9× 88 0.8× 44 1.4k
C E Halstenson United States 14 390 0.9× 191 1.0× 91 0.6× 269 2.4× 40 0.4× 28 836
Peggy Gandia France 16 404 1.0× 293 1.5× 152 1.0× 143 1.3× 41 0.4× 75 1.0k
H Laufen Germany 22 325 0.8× 470 2.4× 78 0.5× 365 3.2× 89 0.8× 76 1.5k
J.M. Brogard France 14 308 0.7× 119 0.6× 106 0.7× 53 0.5× 119 1.1× 63 672

Countries citing papers authored by Mark A. Gill

Since Specialization
Citations

This map shows the geographic impact of Mark A. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Gill more than expected).

Fields of papers citing papers by Mark A. Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Gill. The network helps show where Mark A. Gill may publish in the future.

Co-authorship network of co-authors of Mark A. Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Gill. A scholar is included among the top collaborators of Mark A. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Gill. Mark A. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jakubowski, Kelly, et al.. (2023). Comparing music‐ and food‐evoked autobiographical memories in young and older adults: A diary study. British Journal of Psychology. 114(3). 580–604. 11 indexed citations
2.
Gill, Mark A., et al.. (2013). Investigating nicotinic acetylcholine receptor expression in neonicotinoid resistant Myzus persicae FRC. Pesticide Biochemistry and Physiology. 107(3). 293–298. 13 indexed citations
3.
Beringer, Paul M., Xiyun Zhang, Levita Hidayat, et al.. (2008). Lack of Effect of P‐glycoprotein Inhibition on Renal Clearance of Dicloxacillin in Patients with Cystic Fibrosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(7). 883–894. 16 indexed citations
4.
Belzberg, Howard, Jay Zhu, Edward E. Cornwell, et al.. (2004). Imipenem Levels Are Not Predictable in the Critically Ill Patient. The Journal of Trauma: Injury, Infection, and Critical Care. 56(1). 111–117. 38 indexed citations
5.
Beringer, Paul M., et al.. (2004). Pharmacokinetics of Ibuprofen in Children with Cystic Fibrosis. Clinical Pharmacokinetics. 43(3). 145–156. 6 indexed citations
6.
Williams, Bradley R., et al.. (2003). A review of rivastigmine: A reversible cholinesterase inhibitor. Clinical Therapeutics. 25(6). 1634–1653. 94 indexed citations
7.
Louie, Stan G., et al.. (2002). Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease. Current Opinion in Pulmonary Medicine. 8(6). 521–528. 22 indexed citations
8.
Inagaki, Kazuhiro, et al.. (2002). A Wide Interindividual Variability of Urinary 6β-Hydroxycortisol to Free Cortisol in 487 Healthy Japanese Subjects in Near Basal Condition. Therapeutic Drug Monitoring. 24(6). 722–727. 24 indexed citations
9.
Montgomery, Megan J., Paul M. Beringer, Stan G. Louie, & Mark A. Gill. (2000). Estimation of Creatinine Clearance in Patients With Metastatic Ovarian Cancer. Therapeutic Drug Monitoring. 22(6). 695–700. 10 indexed citations
10.
Jhee, Stanford S., et al.. (1995). Piperacillin‐Tazobactam Pharmacokinetics in Patients With Intraabdominal Infections. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(4). 472–478. 10 indexed citations
11.
Jhee, Stanford S., Mark A. Gill, Albert E. Yellin, et al.. (1995). Pharmacoeconomics of Piperacillin/Tazobactam and Imipenem/Cilastatin in the treatment of patients with intra-abdominal infections. Clinical Therapeutics. 17(1). 126–135. 13 indexed citations
12.
Jhee, Stanford S., et al.. (1994). Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration. American Journal of Health-System Pharmacy. 51(9). 1201–1204. 4 indexed citations
13.
Choi, Jun‐Shik, et al.. (1994). Stability of paclitaxel and fluconazole during simulated Y-site administration. American Journal of Health-System Pharmacy. 51(21). 2704–2706. 3 indexed citations
14.
Okamoto, Mark P., Mark A. Gill, Alfred Chin, et al.. (1992). Tissue Concentrations of Cefepime in Acute Cholecystitis Patients. Therapeutic Drug Monitoring. 14(3). 220–225. 15 indexed citations
15.
Gill, Mark A., et al.. (1992). Pharmacokinetic Population Parameters for Aminoglycosides in Cholecystitis Patients. Therapeutic Drug Monitoring. 14(2). 107–111. 11 indexed citations
16.
Sclar, David A., Tracy L. Skaer, Alfred Chin, Mark P. Okamoto, & Mark A. Gill. (1991). Utility of a transdermal delivery system for antihypertensive therapy. Part 2. The American Journal of Medicine. 91(1). S57–S60. 13 indexed citations
17.
Sclar, David A., Tracy L. Skaer, Alfred Chin, Mark P. Okamoto, & Mark A. Gill. (1991). Utility of a transdermal delivery system for antihypertensive therapy. Part 1. The American Journal of Medicine. 91(1). S50–S56. 35 indexed citations
18.
Ruff, Michael R., Craig C. Smith, Howard S. Jaffe, et al.. (1991). Pharmacokinetics of peptide T in patients with Acquired Immunodeficiency Syndrome (AIDS). Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15(6). 791–801. 6 indexed citations
19.
Gill, Mark A., et al.. (1979). Improved method for estimating initial heparin infusion rates. American Journal of Health-System Pharmacy. 36(6). 782–784. 10 indexed citations
20.
Gill, Mark A. & Clarence T. Ueda. (1976). Novel method for the determination of pediatric dosages. American Journal of Health-System Pharmacy. 33(4). 389–394. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J J Schentag Breakdown of academic impact, for papers by Allan H. Price Breakdown of academic impact, for papers by Karen I. Plaisance Breakdown of academic impact, for papers by Klaus Borner Breakdown of academic impact, for papers by Lee B. Barradell Breakdown of academic impact, for papers by Jaya Natarajan Breakdown of academic impact, for papers by C E Halstenson Breakdown of academic impact, for papers by Peggy Gandia Breakdown of academic impact, for papers by H Laufen Breakdown of academic impact, for papers by J.M. Brogard
Rankless by CCL
2026